Latest News

Journal Articles

Bacterial

ECCMID17: DNA fingerprinting suggests food may be a source of C. difficile

Lysibodies – a promising new weapon against drug-resistant bacteria?

Bacteriophages provide promising results against multidrug-resistant E.coli

Clostridium Difficile Infection

ECCMID17: DNA fingerprinting suggests food may be a source of C. difficile

Inhibition of MRSA and of Clostridium difficile by durancin 61A: synergy with bacteriocins and antibiotics

New study suggests that vancomycin should be the antibiotic of choice for Clostridium difficile infections

E. Coli

Bacteriophages provide promising results against multidrug-resistant E.coli

How can nanosensors detect bacterial contamination before it ever reaches the dinner table?

From drug developer to antibiotic hunter – an interview with Mark Blaskovich

H. Pylori

Direct detection of Helicobacter pylori in biopsy specimens using a high-throughput multiple genetic detection system

MRSA

Lysibodies – a promising new weapon against drug-resistant bacteria?

Inhibition of MRSA and of Clostridium difficile by durancin 61A: synergy with bacteriocins and antibiotics

Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses

Salmonella

How can nanosensors detect bacterial contamination before it ever reaches the dinner table?

Host–pathogen interactions: how do pathogens escape the process of autophagy?

WHO publishes list of antibiotic-resistant bacteria most in need of new antibiotics

Tuberculosis

Conference report – nontuberculosis mycobacterial symposium

IDHTalks at the CICH seminar series: Pediatric tuberculosis – why aren’t we winning the fight?

Infographic: Tuberculosis – the story so far and the strategy moving forwards

Fungal

Fungi – antibiotics of the future?

From drug developer to antibiotic hunter – an interview with Mark Blaskovich

New production method could increase the availability of treatment for cryptococcal meningitis

Aspergillosis

Diagnostics and susceptibility testing in Aspergillus

Candidiasis

From drug developer to antibiotic hunter – an interview with Mark Blaskovich

Loss of immune control in HIV-infected patients: how does mucosal candidiasis occur?

Coccidioidomycosis

Coccidioidomycosis – an update on current clinical trials

Cryptococcal Meningitis

From drug developer to antibiotic hunter – an interview with Mark Blaskovich

New production method could increase the availability of treatment for cryptococcal meningitis

The putative autophagy regulator Atg7 affects the physiology and pathogenic mechanisms of Cryptococcus neoformans

Parasitic

Parasitic proteins crucial for cell traversal activity identified

Contemporary infectious exanthems: an update

Circadian control in sleeping sickness parasite uncovered

Helminthic Infections

Nodding syndrome: pathology and prevention – an interview with Robert Colebunders

Genome-wide miRNAs expression profiles of Schistosoma japonicum schistosomula in response to artesunate

Malaria

Parasitic proteins crucial for cell traversal activity identified

Rapid diagnostic tests for malaria: past, present and future

Could a new vaccine help protect against a broad range of mosquito-borne diseases?

Neglected Tropical Diseases

Circadian control in sleeping sickness parasite uncovered

New therapeutic targets uncovered for leishmaniasis

Nodding syndrome: pathology and prevention – an interview with Robert Colebunders

Protozoan Infections

Parasitic proteins crucial for cell traversal activity identified

New therapeutic targets uncovered for leishmaniasis

Rapid diagnostic tests for malaria: past, present and future

Viral

ECCMID17: Could Wolbachia be a promising tool to control Zika?

Infographic: The facts about immunization

How can the gut microbiota affect immune recovery in HIV-infected individuals?

Hepatitis

Infographic: The facts about immunization

Could hepatitis infection increase the risk of Parkinson’s disease?

Is hepatitis C fully treatable with oral direct-acting agents?

Herpes

Targeting the human TREX complex to prevent herpesvirus replication: what is new?

Could nanoparticles reactivate latent herpes infections?

Study points to BNRF1 as responsible for EBV-associated tumor formation